
Tiratricol
Tiratricol is a monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome. It has a role as an antiviral agent, a nutraceutical, a thyroid hormone, an anti-obesity agent, an EC 1.3.5.2 [dihydroorotate dehydrogenase (quinone)] inhibitor and a human metabolite. It is a monocarboxylic acid, a member of phenols, an aromatic ether and an organoiodine compound. — ChEBI
- IUPAC name
- 2-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid
- Molecular formula
- C14H9I3O4
- Molecular weight
- 621.93 g/mol
- Exact mass
- 621.7635 Da
- XLogP3
- 4.5
- Topological polar surface area
- 66.8 Ų
- Hydrogen-bond donors
- 2
- Hydrogen-bond acceptors
- 4
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
16 more reported names
External database identifiers
- ChEBI:CHEBI:40021
- ChEMBL:CHEMBL41632
- EPA DTXSID:DTXSID2045232
- PubMed:40549098
- PubMed:35435491
- PubMed:33049310
- PubMed:31566444
- PubMed:31077750
- PubMed:29458080
- PubMed:25455453
- PubMed:23037998
- PubMed:22947347
- PubMed:22285287
- PubMed:21938413
- PubMed:21846139
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.